C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
NCT00688454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3392
Last updated 2009-04-09
Summary
The study explores efficacy and safety of the lipid-lowering therapy with CRESTOR in statin-naive patients and in patients with previously unsuccessful statin therapy. This study was designed to investigate the dynamic of the lipid parameters and therapy tolerability during 8-10 weeks treatment with CRESTOR
Conditions
- Hypercholesteremia
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Completion
- 2008-01-31
More Related Trials
-
to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers
NCT02289430 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients
NCT03949374 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Crestor on Lipoprotein Metabolism in Humans
NCT00214617 ·Status: COMPLETED ·Phase: PHASE4
-
CRESTOR Athero Imaging Head to Head IVUS Study
NCT00620542 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
NCT02280590 ·Status: COMPLETED ·Phase: PHASE4
-
12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
NCT00525824 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg
NCT00653445 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C
NCT00446940 ·Status: COMPLETED ·Phase: PHASE2
-
Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
NCT00683618 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers
NCT01415466 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
NCT00631189 ·Status: COMPLETED ·Phase: PHASE4
-
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
NCT00695539 ·Status: COMPLETED
-
STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges
NCT00654537 ·Status: COMPLETED ·Phase: PHASE3
-
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
NCT00654602 ·Status: COMPLETED ·Phase: PHASE3
-
To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
NCT00726362 ·Status: COMPLETED
-
Influence of OATP1B1 and BRCP Genotype on Rosuvastatin PK, PD and Lipidomics in Hyperlipidemic Patients
NCT01466608 ·Status: COMPLETED ·Phase: PHASE4
-
Crestor Versus Placebo in Subjects With Heart Failure
NCT00206310 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
NCT00934258 ·Status: AVAILABLE
-
Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
NCT00335699 ·Status: COMPLETED ·Phase: PHASE4
-
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
NCT00239330 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)
NCT00654225 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
NCT05088343 ·Status: COMPLETED ·Phase: PHASE1
-
Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)
NCT00653744 ·Status: COMPLETED ·Phase: PHASE3
-
DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia
NCT00241488 ·Status: COMPLETED ·Phase: PHASE3
-
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
NCT01352897 ·Status: COMPLETED